Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs
Top Performing Leveraged/Inverse ETFs: 11/16/2025
New FDA Director Could Sway Biotech ETFs
As M&A Deals Rise, Can Biotech Pharma Break Loose?
Top Performing Leveraged/Inverse ETFs: 09/07/2025
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Top Performing Leveraged/Inverse ETFs: 04/20/2025
Rising Number of Flu Cases Could Elevate These ETFs
Top Performing Leveraged/Inverse ETFs: 01/26/2025
There Could Be Value in Healthcare Stocks Ahead of 2025
Top Performing Leveraged/Inverse ETFs: 12/01/2024
Top Performing Leveraged/Inverse ETFs: 07/28/2024
Top Performing Leveraged/Inverse ETFs: 07/14/2024
Top Performing Leveraged/Inverse ETFs: 05/05/2024
Top Performing Leveraged/Inverse ETFs: 03/03/2024
Early IPO Activity Could Spell Bullishness for Biotech Industry
Top Performing Leveraged/Inverse ETFs: 12/17/2023
Top Performing Leveraged/Inverse ETFs: 12/03/2023
Top Performing Leveraged/Inverse ETFs: 11/19/2023
Top Performing Leveraged/Inverse ETFs: 11/05/2023
Top Performing Leveraged/Inverse ETFs: 05/07/2023